165 related articles for article (PubMed ID: 22475312)
1. Monomeric C-reactive protein alters fibrin clot properties on endothelial cells.
Li R; Ren M; Luo M; Chen N; Zhang Z; Luo B; Wu J
Thromb Res; 2012 May; 129(5):e251-6. PubMed ID: 22475312
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory changes in human umbilical cord vein endothelial cells can be induced neither by native nor by modified CRP.
Oroszlán M; Herczenik E; Rugonfalvi-Kiss S; Roos A; Nauta AJ; Daha MR; Gombos I; Karádi I; Romics L; Prohászka Z; Füst G; Cervenak L
Int Immunol; 2006 Jun; 18(6):871-8. PubMed ID: 16636017
[TBL] [Abstract][Full Text] [Related]
3. Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains.
Ji SR; Ma L; Bai CJ; Shi JM; Li HY; Potempa LA; Filep JG; Zhao J; Wu Y
FASEB J; 2009 Jun; 23(6):1806-16. PubMed ID: 19136614
[TBL] [Abstract][Full Text] [Related]
4. Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface.
Campbell RA; Overmyer KA; Bagnell CR; Wolberg AS
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2247-54. PubMed ID: 18974382
[TBL] [Abstract][Full Text] [Related]
5. Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils.
Khreiss T; József L; Potempa LA; Filep JG
Circ Res; 2005 Sep; 97(7):690-7. PubMed ID: 16123332
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of megakaryocytopoiesis in mice by human modified C-reactive protein (mCRP).
Potempa LA; Motie M; Wright KE; Crump BL; Radosevich JA; Sakai N; Lai G; Tanaka K; Kojima E; Tsuboi A
Exp Hematol; 1996 Feb; 24(2):258-64. PubMed ID: 8641350
[TBL] [Abstract][Full Text] [Related]
7. Native and modified C-reactive protein bind different receptors on human neutrophils.
Heuertz RM; Schneider GP; Potempa LA; Webster RO
Int J Biochem Cell Biol; 2005 Feb; 37(2):320-35. PubMed ID: 15474978
[TBL] [Abstract][Full Text] [Related]
8. A redox switch in C-reactive protein modulates activation of endothelial cells.
Wang MY; Ji SR; Bai CJ; El Kebir D; Li HY; Shi JM; Zhu W; Costantino S; Zhou HH; Potempa LA; Zhao J; Filep JG; Wu Y
FASEB J; 2011 Sep; 25(9):3186-96. PubMed ID: 21670067
[TBL] [Abstract][Full Text] [Related]
9. Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice.
Schwedler SB; Amann K; Wernicke K; Krebs A; Nauck M; Wanner C; Potempa LA; Galle J
Circulation; 2005 Aug; 112(7):1016-23. PubMed ID: 16087790
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cells organize fibrin clots into structures that are more resistant to lysis.
Jerome WG; Handt S; Hantgan RR
Microsc Microanal; 2005 Jun; 11(3):268-77. PubMed ID: 16060980
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.
Eisenhardt SU; Habersberger J; Murphy A; Chen YC; Woollard KJ; Bassler N; Qian H; von Zur Muhlen C; Hagemeyer CE; Ahrens I; Chin-Dusting J; Bobik A; Peter K
Circ Res; 2009 Jul; 105(2):128-37. PubMed ID: 19520972
[TBL] [Abstract][Full Text] [Related]
12. mCRP triggers angiogenesis by inducing F3 transcription and TF signalling in microvascular endothelial cells.
Peña E; de la Torre R; Arderiu G; Slevin M; Badimon L
Thromb Haemost; 2017 Jan; 117(2):357-370. PubMed ID: 27808345
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein isoforms differ in their effects on thrombus growth.
Molins B; Peña E; Vilahur G; Mendieta C; Slevin M; Badimon L
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2239-46. PubMed ID: 18787187
[TBL] [Abstract][Full Text] [Related]
14. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m).
Ji SR; Wu Y; Zhu L; Potempa LA; Sheng FL; Lu W; Zhao J
FASEB J; 2007 Jan; 21(1):284-94. PubMed ID: 17116742
[TBL] [Abstract][Full Text] [Related]
15. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
16. Monomeric C-reactive protein modulates classic complement activation on necrotic cells.
Mihlan M; Blom AM; Kupreishvili K; Lauer N; Stelzner K; Bergström F; Niessen HW; Zipfel PF
FASEB J; 2011 Dec; 25(12):4198-210. PubMed ID: 21856781
[TBL] [Abstract][Full Text] [Related]
17. Relationship between endothelial tissue factor and thrombogenesis under blood flow conditions.
Diquélou A; Dupouy D; Gaspin D; Constans J; Sié P; Boneu B; Sakariassen KS; Cadroy Y
Thromb Haemost; 1995 Aug; 74(2):778-83. PubMed ID: 8585021
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.
Montero I; Orbe J; Varo N; Beloqui O; Monreal JI; Rodríguez JA; Díez J; Libby P; Páramo JA
J Am Coll Cardiol; 2006 Apr; 47(7):1369-78. PubMed ID: 16580524
[TBL] [Abstract][Full Text] [Related]
19. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment.
Undas A; Kaczmarek P; Sladek K; Stepien E; Skucha W; Rzeszutko M; Gorkiewicz-Kot I; Tracz W
Thromb Haemost; 2009 Dec; 102(6):1176-82. PubMed ID: 19967149
[TBL] [Abstract][Full Text] [Related]
20. Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction.
Habersberger J; Strang F; Scheichl A; Htun N; Bassler N; Merivirta RM; Diehl P; Krippner G; Meikle P; Eisenhardt SU; Meredith I; Peter K
Cardiovasc Res; 2012 Oct; 96(1):64-72. PubMed ID: 22798388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
